Skip to main content
Clinical Trials/JPRN-UMIN000037308
JPRN-UMIN000037308Completed未知

Observational, prospective study to examine association values of Interferon-Gamma Release Assay (IGRA) before and after treatment and clinical response or adverse events in patients with lung cancer who received cytotoxic cancer chemotherapy containing platinum with or without Immune Checkpoint Inhibitor (ICI) - Observational, prospective study to examine association values of Interferon-Gamma Release Assay (IGRA) before and after treatment and clinical response or adverse events in patients with lung cancer who received cytotoxic cancer chemotherapy containing platinum with or without Immune Checkpoint Inhibitor (ICI)

Osaka Prefectural Hospital Organization Osaka Habikino Medical Center0 sites46 target enrollmentStarted: July 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
46
Observational, prospective study to... | Clinical Trial